TABLE 1.

Considerations for involuntary medication^a

Ethical	Clinical	Access
Long-term goals	Past trials	Hospital formulary
Patient input in choice of antipsychotic	Use of short-acting antipsychotics	Cost (including cost to patient as outpatient)
Criteria for involuntary treatment	Comorbid conditions Adverse effects Route Dosing interval Requirement for oral overlap	Drug replacement or sample program availability Jail formulary, ability to administer LAIAs, and ability to adjust medication times

LAIAs = long-acting injectable antipsychotics.

^aBased on expert opinion.